Prostatilen-Zinc
№ 5
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Rectal suppositories
ATC code
G04CX
RX/OTC
OTC
Registration certificate
UA/7223/01/01
General properties
Pharmacotherapeutic group
Agents used in benign prostatic hypertrophy.
Therapeutic indications
- Treatment and prevention of chronic prostatitis, benign prostatic hyperplasia;
- complications after surgery on the prostate gland, as well as sexual dysfunction, male infertility.
Contraindications
Hypersensitivity to the drug, renal failure, myocardial infarction, cardio. Hypersensitivity to cattle proteins.
Pharmaceutical characteristics
Main physicochemical properties
Suppositories of white with yellowish or grayish tint color, bullet-shaped form. Presence of plaque on the surface of a suppository is accepted.
Shelf life
3 years.
Storage
Keep out of reach of children at temperature not exceeding 25 °С.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
